Market Tracker

02/24 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.63
Delayed Data
As of Feb 24
 -0.0155 / -2.40%
Today’s Change
0.60
Today|||52-Week Range
2.00
-48.78%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.65
Today’s open0.63
Day’s range0.60 - 0.63
Volume39,909
Average volume (3 months)106,721
Market cap$24.9M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...-0.06-2.73%
MRNSMarinus Pharmaceutic...+0.06+4.58%
VICLVical Inc+0.02+0.78%
APRIApricus Biosciences ...-0.01-0.38%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts